银华国证港股通创新药ETF发起式联接C
(023930.jj ) 港股通创新药 (半年) 银华基金管理股份有限公司
基金经理马君谭普景基金类型指数型基金(ETF,联接型)成立日期2025-04-18总资产规模5.27亿 (2026-03-31) 基金净值1.0972 (2026-07-10) 管理费用率0.50%管托费用率0.10% (2026-06-17) 成立以来分红再投入年化收益率8.21% (2839 / 6108)
备注 (0): 双击编辑备注
发表讨论

银华国证港股通创新药ETF发起式联接C(023930) - 历史基金净值数据曲线

最后更新于:2026-07-10

数据选项
加载中......
银华国证港股通创新药ETF发起式联接C历史净值,最多展示50条数据。
日期基金净值基金累计净值
2026-07-101.09721.0972
2026-07-091.07081.0708
2026-07-081.07761.0776
2026-07-071.08741.0874
2026-07-061.12651.1265
2026-07-031.09911.0991
2026-07-021.04981.0498
2026-07-010.99240.9924
2026-06-300.99310.9931
2026-06-291.01281.0128
2026-06-260.94980.9498
2026-06-250.95890.9589
2026-06-240.97180.9718
2026-06-230.96060.9606
2026-06-220.95550.9555
2026-06-180.97550.9755
2026-06-170.95940.9594
2026-06-160.97570.9757
2026-06-150.99390.9939
2026-06-120.99430.9943
2026-06-110.96520.9652
2026-06-100.97580.9758
2026-06-090.95840.9584
2026-06-080.96830.9683
2026-06-050.99070.9907
2026-06-041.00481.0048
2026-06-031.01671.0167
2026-06-021.04011.0401
2026-06-011.06751.0675
2026-05-291.08551.0855
2026-05-281.04161.0416
2026-05-271.08781.0878
2026-05-261.09081.0908
2026-05-251.11201.1120
2026-05-221.11271.1127
2026-05-211.11211.1121
2026-05-201.09731.0973
2026-05-191.09651.0965
2026-05-181.10481.1048
2026-05-151.13631.1363
2026-05-141.16131.1613
2026-05-131.17931.1793
2026-05-121.19911.1991
2026-05-111.20631.2063
2026-05-081.20721.2072
2026-05-071.22541.2254
2026-05-061.20511.2051
2026-04-301.21481.2148
2026-04-291.21061.2106
2026-04-281.21511.2151